A new study in JAMA Network Open reports on this phenomenon at three Harvard, Boston, Massachusetts, campuses.
BMS, VantAI team up; CRISPR Therapeutics to raise $280M; Ono Pharma’s deal with Shattuck Labs
Plus, news about Areteia Therapeutics, Sudo Biosciences, Cidara Therapeutics, Xspray Pharma and Sana Biotechnology: Bristol Myers Squibb inks deal with VantAI: The pair plan to